Press release
Integrated Radionuclide Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global leading market research publisher QYResearch published the release of its latest report, "Integrated Radionuclide Medicine - Global Market Share, Ranking, Sales, and Demand Forecast 2025-2031". This in-depth report provides a complete analysis of the global Integrated Radionuclide Medicine market, offering critical insights into market size, share, demand, industry development status, and future forecasts. Whether you're a stakeholder, investor, or industry player, this report equips you with the data and strategies needed to stay ahead in a rapidly evolving market.
The global market for Integrated Radionuclide Medicine was estimated to be worth US$ 1280 million in 2024 and is forecast to a readjusted size of US$ 3006 million by 2031 with a CAGR of 13.1% during the forecast period 2025-2031.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4817953/integrated-radionuclide-medicine
Why This Report is a Must-Have
Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.
Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.
Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.
Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.
Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.
Market Segmentation
The Integrated Radionuclide Medicine market is segmented as follows:
By Company:
Novartis
Bayer AG
Curium
ITM Radiopharma
POINT Biopharma Global
Lantheus Holdings
Clarity Pharmaceuticals
RadioMedix
Telix Pharmaceuticals
ARTBIO
RayzeBio
Convergent Therapeutics
Mariana Oncology
Ratio Therapeutics
Advanced Accelerator Applications
Cardinal Health
GE HealthCare
Jubilant Pharma
IRE ELiT
NTP Radioisotopes
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Beijing Sinotau International Pharmaceutical Technology
Hexin Pharmaceutical Technology
Fulian Pharmaceuticals
By Type:
Diagnostic Radionuclide Drugs
Integrated Diagnostic and Therapeutic Radionuclide Drugs
By Application:
Healthcare Industry
Nuclear Medicine Industry
Biomedical Research and Development Industry
Others
What You'll Gain from This Report
In-Depth Regional Analysis: Explore market potential across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Competitive Intelligence: Profiles of key players, including their sales, revenue, product portfolios, and recent developments.
Market Dynamics: Understand the latest trends, driving factors, and risks impacting the industry.
Actionable Insights: Make informed business decisions with data-driven strategies and forecasts.
Each chapter of the report provides detailed information for readers to further understand the Integrated Radionuclide Medicine market:
1. Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
2. Chapter Two: Detailed analysis of Integrated Radionuclide Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
3. Chapter Three: Sales, revenue of Integrated Radionuclide Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
4. Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
5. Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
6. Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
7. Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
8. Chapter Twelve: Analysis of sales channel, distributors and customers.
9. Chapter Thirteen: Research Findings and Conclusion.
Key Highlights of the Report
Market Size & Growth Potential: Quantitative analysis of the market's current and future size, with region-specific insights.
Production Volume Analysis: Detailed evaluation of production trends by type and region from 2020 to 2031.
Strategic Insights: Identify profit opportunities, develop targeted strategies, and allocate resources effectively.
Industry Challenges & Solutions: Learn how to overcome market restraints and leverage growth drivers.
To contact us and get this report: https://www.qyresearch.com/contact-us
Why Choose QYResearch?
18+ Years of Expertise: Trusted by over 68,000 companies worldwide.
Global Presence: Offices in 6 countries and partnerships in over 30 regions.
24/7 Support: Dedicated team ready to assist you with any queries.
Customized Solutions: Tailored reports to meet your specific business needs.
Get Your Free Sample Report Today!
Don't miss out on this opportunity to gain a competitive edge. Requested your free sample PDF now and explore the insights that can transform your business strategy.
Contact Us
For more information or to purchase the full report, reach out to us:
QY Research Inc.
Address: 17890 Castleton Street, Suite 369, City of Industry, CA 91748, USA
Email: tytaoyue@qyresearch.com , global@qyresearch.com
Phone: 0086-159 1594 1389(CN)
Tel: 001-626-294-2442(US)
Website: https://www.qyresearch.com
About QYResearch:
Founded in 2007, QYResearch is a leading global market research and consulting firm. With a vast database and a team of experienced analysts, we provide actionable insights and data-driven solutions to help businesses thrive in competitive markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Integrated Radionuclide Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 here
News-ID: 4131494 • Views: …
More Releases from QY Research Inc.
PCI Serial Port Cards Detailed Analysis 2025-2031: Market Size, Future Prospects …
The global market for PCI Serial Port Cards was estimated to be worth US$ 336 million in 2024 and is forecast to a readjusted size of US$ 430 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
2025 Market Report by QYResearch "PCI Serial Port Cards - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides an extensive examination of PCI Serial Port…
Unity Gain VHF/UHF Dual Band Antenna Market Analysis by Type, Application, and M …
The global market for Unity Gain VHF/UHF Dual Band Antenna was estimated to be worth US$ 207 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Global Market Research Publisher QYResearch announces the release of its lastest report "Unity Gain VHF/UHF Dual Band Antenna - Global Market Share and Ranking, Overall Sales and…
Superfood Bars Global Market Market Size, Sales Volume, Price, Growth Rate Analy …
The global market for Superfood Bars was estimated to be worth US$ 3013 million in 2024 and is forecast to a readjusted size of US$ 5139 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Global Leading Market Research Publisher QYResearch announces the release of its latest report "Superfood Bars - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and…
Cooking Oil Quality Test Strips Worldwide Market Report - Market Share, Trends, …
The global market for Cooking Oil Quality Test Strips was estimated to be worth US$ 266 million in 2024 and is forecast to a readjusted size of US$ 406 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Global Market Research Publisher QYResearch announces the release of its lastest report "Cooking Oil Quality Test Strips - Global Market Share and Ranking, Overall Sales and Demand Forecast…
More Releases for Radionuclide
Radionuclide Drug Conjugates (RDCs) Market Growth Set to Surge Significantly by …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook And Industry Analysis 2031"
The Global Radionuclide Drug Conjugates (RDCs) Market is expected to grow with a CAGR…
Radionuclide Therapy Equipment Market Size And Global Industry Forecast 2034
" In 2024, the global radionuclide therapy equipment market is valued at approximately $4.3 billion, driven by increasing prevalence of cancer and advancements in targeted therapies. The market is projected to reach around $7.8 billion by 2034, reflecting significant growth opportunities primarily attributed to technological advancements, enhanced diagnostic capabilities, and a rising focus on personalized medicine. "
Exactitude Consultancy., Ltd. released a research report titled "Radionuclide Therapy Equipment Market". This report…
Antibody-radionuclide Conjugates Market Share Research Report 2025
On Mar 6, 2025, Global Info Research released a research report titled "Global Antibody-radionuclide Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Antibody-radionuclide Conjugates market from 2020 to 2031. Including the market size and development trends of Antibody-radionuclide Conjugates Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a…
Radionuclide Drug Conjugates (RDCs) Market Robust Expansion is expected to 2031
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Peptide Receptor Radionuclide Therapy Market Analysis, Size, Current Scenario an …
Peptide Receptor Radionuclide Therapy Market is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of neuroendocrine tumors is expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. The establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT).
Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer…
